Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2010 | 12-2009 | |
| Sales | 15,638,000 | 14,214,196 |
| Cost of Goods | 4,293,000 | 4,056,390 |
| Gross Profit | 11,345,000 | 10,157,806 |
| Operating Expenses | 6,628,000 | 5,056,012 |
| Operating Income | 4,717,000 | 5,101,794 |
| Other Income | 119,000 | 848,523 |
| Pre-tax Income | 4,836,000 | 5,950,317 |
| Income Tax | 658,000 | 1,313,802 |
| Net Income Continuous | 4,178,000 | 4,636,515 |
| Net Income | $4,178,000 | $4,636,515 |
| EPS Basic Total Ops | 0.27 | 0.30 |
| EPS Diluted Total Ops | 0.27 | 0.30 |
| EBITDA(a) | $6,020,000 | $5,799,286 |